{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:35:28Z","timestamp":1790105728949,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"vor","delay-in-days":1035,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Kuwait University Research Administration","award":["MI 116"],"award-info":[{"award-number":["MI 116"]}]},{"name":"Kuwait University Research Administration","award":["MI 06\/02"],"award-info":[{"award-number":["MI 06\/02"]}]},{"name":"Kuwait University Research Administration","award":["MI 02\/04"],"award-info":[{"award-number":["MI 02\/04"]}]},{"name":"Kuwait University Research Administration","award":["YM 03\/06"],"award-info":[{"award-number":["YM 03\/06"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jiph.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,11,9]],"date-time":"2013-11-09T10:45:35Z","timestamp":1383993935000},"page":"75-91","source":"Crossref","is-referenced-by-count":78,"title":["Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Suhail","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiman","family":"Mokaddas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2013.09.001_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1465-9921-11-169","article-title":"New approaches in the diagnosis and treatment of latent tuberculosis infection","volume":"11","author":"Ahmad","year":"2010","journal-title":"Respiratory Research"},{"key":"10.1016\/j.jiph.2013.09.001_bib0010","series-title":"Global tuberculosis report 2012. WHO report 2012. WHO\/HTM\/TB\/2008.393","first-page":"1","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.jiph.2013.09.001_bib0015","doi-asserted-by":"crossref","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection","volume":"8","author":"Pawlowski","year":"2012","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.jiph.2013.09.001_bib0020","first-page":"319","article-title":"Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996\u20132005","volume":"12","author":"Mokaddas","year":"2008","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0025","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5588\/ijtld.11.0503","article-title":"The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis","volume":"15","author":"Harries","year":"2011","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mimet.2008.06.015","article-title":"Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis","volume":"75","author":"Palomino","year":"2008","journal-title":"Journal of Microbiological Methods"},{"key":"10.1016\/j.jiph.2013.09.001_bib0035","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(09)60331-7","article-title":"Epidemiology of antituberculosis drug resistance 2002\u20132007: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance","volume":"373","author":"Wright","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2013.09.001_bib0040","series-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. WHO\/HTM\/TB\/2010.3","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.jiph.2013.09.001_bib0045","doi-asserted-by":"crossref","first-page":"860","DOI":"10.5588\/ijtld.12.0180","article-title":"Diagnosis of tuberculosis and drug resistance: what can new tools bring us?","volume":"16","author":"Drobniewski","year":"2012","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/fmb.11.133","article-title":"Current developments and future perspectives for TB diagnostics","volume":"7","author":"Palomino","year":"2012","journal-title":"Future Microbiology"},{"key":"10.1016\/j.jiph.2013.09.001_bib0055","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0060","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jinf.2012.02.012","article-title":"Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB\/RIF assay: a meta-analysis","volume":"64","author":"Chang","year":"2012","journal-title":"Journal of Infection"},{"key":"10.1016\/j.jiph.2013.09.001_bib0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"Treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/thoraxjnl-2012-201756","article-title":"Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes","volume":"68","author":"Jim\u00e9nez-Corona","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jiph.2013.09.001_bib0075","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5588\/ijtld.12.0083","article-title":"The chemotherapy of tuberculosis: past, present and the future","volume":"16","author":"Mitchison","year":"2012","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","article-title":"Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis","volume":"9","author":"Orenstein","year":"2009","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.jiph.2013.09.001_bib0085","first-page":"3","article-title":"New approaches in the diagnosis and treatment of susceptible, multidrug-resistant and extensively drug-resistant tuberculosis","volume":"44","author":"Ahmad","year":"2012","journal-title":"Kuwait Medical Journal"},{"key":"10.1016\/j.jiph.2013.09.001_bib0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5588\/ijtld.11.0153","article-title":"Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting","volume":"16","author":"Gandhi","year":"2012","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0095","first-page":"605","article-title":"Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"10","author":"Johnson","year":"2006","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.5588\/ijtld.11.0451","article-title":"Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"16","author":"Cox","year":"2012","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0105","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/infdis\/jis460","article-title":"World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?","volume":"207","author":"Dooley","year":"2013","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.jiph.2013.09.001_bib0110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jac\/dks395","article-title":"Is there a place for \u03b2-lactams in the treatment of multidrug-resistant\/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin\/clavulanate","volume":"68","author":"Gonzalo","year":"2013","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis","volume":"358","author":"Zhang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2013.09.001_bib0120","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jac\/dkr173","article-title":"Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs","volume":"66","author":"Almeida Da Silva","year":"2011","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijantimicag.2003.10.004","article-title":"Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East","volume":"23","author":"Ahmad","year":"2004","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.jiph.2013.09.001_bib0130","first-page":"110","article-title":"Performance comparison of four methods for rapid detection of multidrug-resistant Mycobacterium tuberculosis strains","volume":"15","author":"Al-Mutairi","year":"2011","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0135","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0140-6736(93)90417-F","article-title":"Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis","volume":"341","author":"Telenti","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2013.09.001_bib0140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.1038","article-title":"Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes","volume":"44","author":"Comas","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jiph.2013.09.001_bib0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/JCM.05092-11","article-title":"The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin\/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China","volume":"50","author":"Tan","year":"2012","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.jiph.2013.09.001_bib0150","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nm0696-662","article-title":"Mutations in pncA, a gene encoding pyrazinamidase\/nicotinamidedase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus","volume":"2","author":"Scorpio","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0155","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1208813","article-title":"Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis","volume":"333","author":"Shi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jiph.2013.09.001_bib0160","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm0597-567","article-title":"The emb operon, a unique gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol","volume":"3","author":"Telenti","year":"1997","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tube.2006.05.004","article-title":"Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait","volume":"87","author":"Ahmad","year":"2007","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.jiph.2013.09.001_bib0170","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1128\/AAC.40.4.1024","article-title":"Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities","volume":"40","author":"Sreevatsan","year":"1996","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0175","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1128\/JCM.00168-11","article-title":"Streptomycin resistance and lineage-specific polymorphisms in Mycobacterium tuberculosis gidB gene","volume":"49","author":"Spies","year":"2011","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.jiph.2013.09.001_bib0180","doi-asserted-by":"crossref","first-page":"e33275","DOI":"10.1371\/journal.pone.0033275","article-title":"Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review","volume":"7","author":"Georghiou","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jiph.2013.09.001_bib0185","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(12)60734-X","article-title":"Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study","volume":"380","author":"Dalton","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2013.09.001_bib0190","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/JCM.00240-10","article-title":"Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections","volume":"48","author":"Jur\u00e9en","year":"2010","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.jiph.2013.09.001_bib0195","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0140-6736(09)60559-6","article-title":"Fourth-generation fluoroquinolones against tuberculosis","volume":"373","author":"Rieder","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2013.09.001_bib0200","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jac\/dks033","article-title":"gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis","volume":"67","author":"Sirgel","year":"2012","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0205","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/JCM.05188-11","article-title":"Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study","volume":"50","author":"Siddiqi","year":"2012","journal-title":"Journal of Clinical Microbiology"},{"issue":"Suppl 4","key":"10.1016\/j.jiph.2013.09.001_bib0210","doi-asserted-by":"crossref","first-page":"S1110","DOI":"10.1093\/infdis\/jir448","article-title":"Alternative methods of diagnosing drug resistance, what can they do for me?","volume":"204","author":"Moore","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.jiph.2013.09.001_bib0215","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1586\/eri.12.94","article-title":"Molecular diagnostic methods for the detection of Mycobacterium tuberculosis resistance: the potential of high-resolution melting analysis","volume":"10","author":"Lee","year":"2012","journal-title":"Expert Reviews on Anti Infective Therapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1378\/chest.09-0150","article-title":"Clinical efficacy of direct DNA sequencing analysis on sputum specimens for early detection of drug-resistant Mycobacterium tuberculosis in a clinical setting","volume":"137","author":"Choi","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jiph.2013.09.001_bib0225","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1101\/gr.128678.111","article-title":"Microevolution of extensively drug-resistant tuberculosis in Russia","volume":"22","author":"Casali","year":"2012","journal-title":"Genome Research"},{"key":"10.1016\/j.jiph.2013.09.001_bib0230","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s10096-011-1453-1","article-title":"Performance of the GenoType\u00ae MTBDRPlus assay in routine settings: a multicenter study","volume":"31","author":"Mironova","year":"2012","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.jiph.2013.09.001_bib0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/JCM.05274-11","article-title":"GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples","volume":"50","author":"Lacoma","year":"2012","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.jiph.2013.09.001_bib0240","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1164\/rccm.201205-0960OC","article-title":"GenoType MTBDRsl line probe assay shortens time to diagnosis of XDR-TB in a high-throughput diagnostic laboratory","volume":"186","author":"Barnard","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0245","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MCP.0b013e3280f3c0b2","article-title":"The clinical management of drug-resistant tuberculosis","volume":"13","author":"Furin","year":"2007","journal-title":"Current Opinion in Pulmonary Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0250","doi-asserted-by":"crossref","first-page":"e1000150","DOI":"10.1371\/journal.pmed.1000150","article-title":"Standardized treatment of active tuberculosis in patients with previous treatment and\/or with mono-resistant to isoniazid: a systematic review and meta-analysis","volume":"6","author":"Menzies","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0255","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5588\/ijtld.11.0376","article-title":"Clinical outcomes of pyrazinamide-monoresistant Mycobacterium tuberculosis in Quebec","volume":"16","author":"Yee","year":"2012","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-149-2-200807150-00008","article-title":"Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis","volume":"149","author":"Lew","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0265","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"Caminero","year":"2010","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.jiph.2013.09.001_bib0270","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective and inexpensive standardised treatment of multidrug-resistant tuberculosis","volume":"182","author":"Van Deun","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0275","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.ijid.2011.12.018","article-title":"Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis","volume":"16","author":"Gegia","year":"2012","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1016\/j.jiph.2013.09.001_bib0280","doi-asserted-by":"crossref","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","article-title":"Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"4","author":"Johnston","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jiph.2013.09.001_bib0285","doi-asserted-by":"crossref","first-page":"e1001300","DOI":"10.1371\/journal.pmed.1001300","article-title":"Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients","volume":"9","author":"Ahuja","year":"2012","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0290","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/653115","article-title":"Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis","volume":"51","author":"Jacobson","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jiph.2013.09.001_bib0295","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijantimicag.2012.01.012","article-title":"Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections","volume":"39","author":"Amaral","year":"2012","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.jiph.2013.09.001_bib0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tube.2011.11.001","article-title":"Pediatric use of second-line anti-tuberculosis agents: a review","volume":"92","author":"Seddon","year":"2012","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.jiph.2013.09.001_bib0305","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11908-010-0104-5","article-title":"Global impact of multidrug-resistant pulmonary tuberculosis among HIV-infected and other immunocompromised hosts: epidemiology, diagnosis, and strategies for management","volume":"12","author":"Wells","year":"2010","journal-title":"Current Infectious Disease Reports"},{"key":"10.1016\/j.jiph.2013.09.001_bib0310","doi-asserted-by":"crossref","first-page":"e47370","DOI":"10.1371\/journal.pone.0047370","article-title":"Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review","volume":"7","author":"Arentz","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jiph.2013.09.001_bib0315","doi-asserted-by":"crossref","first-page":"e46943","DOI":"10.1371\/journal.pone.0046943","article-title":"Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho","volume":"7","author":"Satti","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jiph.2013.09.001_bib0320","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/dks405","article-title":"Is repositioning of drugs a viable alternative in the treatment of tuberculosis?","volume":"68","author":"Palomino","year":"2013","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0325","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.5588\/ijtld.12.0277","article-title":"New drugs for the treatment of tuberculosis: hope and reality","volume":"16","author":"Grosset","year":"2012","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0330","first-page":"305","article-title":"Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review","volume":"15","author":"Steingart","year":"2011","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jiph.2013.09.001_bib0335","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1128\/AAC.00417-10","article-title":"Characteristic resistance mechanism of Mycobacterium tuberculosis to DC-159a, a new respiratory quinolone","volume":"55","author":"Sekiguchi","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0340","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/AAC.01514-10","article-title":"Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis","volume":"55","author":"Ahmad","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0345","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1517\/13543784.2011.628657","article-title":"Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications","volume":"20","author":"Sharma","year":"2011","journal-title":"Expert Opinion in Investigational Drugs"},{"key":"10.1016\/j.jiph.2013.09.001_bib0350","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tube.2010.07.004","article-title":"Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells","volume":"90","author":"Dhillon","year":"2010","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.jiph.2013.09.001_bib0355","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/AAC.06126-11","article-title":"Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance","volume":"56","author":"Diacon","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0360","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(12)61080-0","article-title":"14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial","volume":"380","author":"Diacon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2013.09.001_bib0365","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4155\/fmc.11.90","article-title":"Nitroimidazoles for the treatment of TB: past, present and future","volume":"3","author":"Mukherjee","year":"2011","journal-title":"Future Medicinal Chemistry"},{"key":"10.1016\/j.jiph.2013.09.001_bib0370","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1128\/AAC.05293-11","article-title":"Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis","volume":"55","author":"Tasneen","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0375","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0380","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/AAC.01326-06","article-title":"Drug therapy of experimental TB: improved outcome by combining SQ109, a new diamine antibiotic with existing TB drugs","volume":"51","author":"Nikonenko","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0385","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/jac\/dkr589","article-title":"SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro","volume":"67","author":"Reddy","year":"2012","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0390","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1749-6632.2011.06330.x","article-title":"The oxazolidinones: past, present, and future","volume":"1241","author":"Shaw","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jiph.2013.09.001_bib0395","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1164\/rccm.200904-0611OC","article-title":"Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis","volume":"180","author":"Williams","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.jiph.2013.09.001_bib0400","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1128\/AAC.00384-12","article-title":"Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis","volume":"56","author":"Williams","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0405","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jiph.2013.09.001_bib0410","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1128\/AAC.01476-12","article-title":"In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis","volume":"56","author":"Lechartier","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0415","doi-asserted-by":"crossref","first-page":"e1000645","DOI":"10.1371\/journal.ppat.1000645","article-title":"High content screening identifies decaprenyl-phosphoribose 2\u2032 epimerase as a target for intracellular antimycobacterial inhibitors","volume":"5","author":"Christophe","year":"2009","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.jiph.2013.09.001_bib0420","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1016\/j.bmcl.2011.07.015","article-title":"Identification of SQ609 as a lead compound from a library of dipiperidines","volume":"21","author":"Bogatcheva","year":"2011","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"10.1016\/j.jiph.2013.09.001_bib0425","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/jac\/dkq495","article-title":"Chemical modification of capuramycins to enhance antibacterial activity","volume":"66","author":"Bogatcheva","year":"2011","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.jiph.2013.09.001_bib0430","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1016\/j.bmc.2008.03.020","article-title":"Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents","volume":"16","author":"Hirano","year":"2008","journal-title":"Bioorganic and Medicinal Chemistry"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603411300124X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603411300124X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T08:49:15Z","timestamp":1564649355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187603411300124X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S187603411300124X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2013.09.001","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}